- 专利标题： N-(5-arylamido-2-methylphenyl)-5-methylisooxazole-4-carboxamide deravative, pharmaceutical acceptable salt thereof, method for preparation therof and FMS kinase inhibitor comprising the same as anactive ingredient
-
申请号： US15510755申请日： 2015-09-17
-
公开(公告)号： US09789086B1公开(公告)日： 2017-10-17
- 发明人: Jung-Mi Hah , Kyung Jin Jung
- 申请人： Industry-University Cooperation Foundation Hanyang University ERICA Campus
- 申请人地址： KR Ansan-si
- 专利权人： INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS
- 当前专利权人： INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS
- 当前专利权人地址： KR Ansan-si
- 代理机构： Lex IP Meister, PLLC
- 优先权： KR10-2014-0125813 20140922
- 国际申请： PCT/KR2015/009787 WO 20150917
- 国际公布： WO2016/047967 WO 20160331
- 主分类号： A61K31/415
- IPC分类号： A61K31/415 ; C07D261/06 ; C07C233/07 ; C07C233/10
摘要：
The present invention relates to N-(5-arylamido-2-methylphenyl)-5-methylisoquoxazole-4-carboxamide derivative, or a pharmaceutically acceptable salt thereof and a pharmaceutical composition comprising same. The compound according to the present invention exhibits an FMS kinase inhibitory activity and thus can be used as pharmaceutical composition for preventing and treating diseases associated therewith.
公开/授权文献
信息查询
